| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E3182100F77 |
| P698 | PubMed publication ID | 21325993 |
| P50 | author | Mahmoud k | Q58022941 |
| P2093 | author name string | Gerhard Opelz | |
| Sabine Scherer | |||
| Bernd Döhler | |||
| Caner Süsal | |||
| Andreas Heinold | |||
| Thuong Hien Tran | |||
| Jörg Ovens | |||
| Andrea Ruhenstroth | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| collaboration | Q1145523 | ||
| P304 | page(s) | 883-887 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report | |
| P478 | volume | 91 |
| Q48186622 | A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies |
| Q38215262 | Acute and chronic antibody-mediated rejection in pediatric kidney transplantation |
| Q51519866 | Algorithm to manage highly sensitized kidney transplant recipients in Poland. |
| Q40220124 | An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade |
| Q54589598 | Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs. |
| Q90023517 | C3d-binding Donor-specific HLA Antibody Is Associated With a High Risk of Antibody-mediated Rejection and Graft Loss in Stable Kidney Transplant Recipients: A Single-center Cohort Study |
| Q36509321 | Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. |
| Q92712461 | Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays |
| Q37058050 | Chronic alloantibody mediated rejection |
| Q38703426 | Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q38446158 | Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy |
| Q47880758 | Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? |
| Q47167963 | Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events. |
| Q86146755 | Concordance and discordance in anti-HLA antibody testing |
| Q51591791 | Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions. |
| Q41514316 | Correlation of Pretransplant Donor-specific Antibody Assay Using Luminex Crossmatch with Graft Outcome in Renal Transplant Patients |
| Q38204851 | Detection of donor-specific antibodies in kidney transplantation |
| Q38607420 | Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics |
| Q45122553 | Different impact of pretransplant anti-HLA antibodies detected by Luminex in highly sensitized renal transplanted patients |
| Q92418179 | Discrepant Antibody Testing Results: Which One to Believe? |
| Q85084898 | Donor-specific HLA antibodies and graft function in children after renal transplantation |
| Q45164939 | Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation |
| Q37149941 | Donor-specific antibodies require preactivated immune system to harm renal transplant. |
| Q85485720 | Effects of mycophenolic acid on highly sensitized patients awaiting kidney transplant |
| Q49644436 | Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies |
| Q27015921 | HLA antibody detection with solid phase assays: great expectations or expectations too great? |
| Q38165753 | HLA antibody screening in kidney transplantation: current guidelines |
| Q38022711 | Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. |
| Q36696536 | Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation |
| Q47130649 | Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome. |
| Q60168146 | Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation |
| Q35452396 | Impact of sensitivity of human leucocyte antigen antibody detection by Luminex technology on graft loss at 1 year |
| Q91936186 | Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation |
| Q44371693 | Influence of test technique on sensitization status of patients on the kidney transplant waiting list |
| Q92418172 | It's About Everything: Validation and Optimization of 96-Well Tray Flow Cytometry Crossmatch |
| Q37854488 | Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch? |
| Q45256335 | Kidney transplantation in immunologically high-risk patients |
| Q35885244 | Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience. |
| Q43829027 | Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death |
| Q41091509 | Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation. |
| Q51545622 | Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity. |
| Q90704811 | Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation |
| Q93063031 | Pretransplant Single Antigen Bead-Detected HLA Antibodies in Kidney Transplant Long-term Outcome: A Single-Center Cohort Experience |
| Q51296997 | Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation. |
| Q41500055 | Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients. |
| Q48300620 | Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays |
| Q35659332 | Recent advances in renal transplantation: antibody-mediated rejection takes center stage |
| Q41826794 | Role and Value of Luminex(®)-Detected HLA Antibodies before and after Kidney Transplantation |
| Q40731475 | Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation |
| Q30317554 | Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes |
| Q92413498 | Shorter Cold Ischemia Time in Deceased Donor Kidney Transplantation Reduces the Incidence of Delayed Graft Function Especially Among Highly Sensitized Patients and Kidneys From Older Donors |
| Q51015580 | Survival in sensitized lung transplant recipients with perioperative desensitization. |
| Q28087773 | The Complement System and Antibody-Mediated Transplant Rejection |
| Q38258153 | The increasing clinical importance of alloantibodies in kidney transplantation |
| Q35547041 | The role of donor-specific HLA alloantibodies in liver transplantation |
| Q52852316 | Tracing clinically relevant HLA antibodies prior to kidney transplantation: Commentary on "Pre-transplant HLA antibodies detected by single antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor specific an |
| Q35790601 | Utility of HLA Antibody Testing in Kidney Transplantation |
| Q92418169 | Virtual Crossmatch: Reality of Perception |
| Q85351871 | Virtual crossmatch in kidney transplantation |
Search more.